Profund Advisors LLC Gilead Sciences, Inc. Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 142,602 shares of GILD stock, worth $13.3 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

142,602

Previous 159,400 10.54%

Holding current value

$13.3 Million

Previous $10.9 Million 9.29%

% of portfolio

0.46%

Previous 0.41%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $1.12 Million - $1.41 Million	-16,798 Reduced 10.54%	142,602 $12 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $1.94 Million - $2.24 Million	30,738 Added 23.89%	159,400 $10.9 Million
Q1 2024 May 08, 2024	SELL	$71.58 - $87.29 $501,990 - $612,164	-7,013 Reduced 5.17%	128,662 $9.42 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $1.34 Million - $1.52 Million	18,318 Added 15.61%	135,675 $11 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $1.72 Million - $1.88 Million	23,312 Added 24.79%	117,357 $8.79 Million
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $559,965 - $638,718	7,367 Added 8.5%	94,045 $7.25 Million
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $8.89 Million - $10.1 Million	-114,960 Reduced 57.01%	86,678 $7.19 Million
Q4 2022 Feb 02, 2023	BUY	$62.32 - $89.47 $20,877 - $29,972	335 Added 0.17%	201,638 $17.3 Million
Q3 2022 Nov 04, 2022	SELL	$59.54 - $68.01 $647,259 - $739,336	-10,871 Reduced 5.12%	201,303 $12.4 Million
Q2 2022 Aug 01, 2022	SELL	$57.72 - $65.01 $1.69 Million - $1.9 Million	-29,199 Reduced 12.1%	212,174 $13.1 Million
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $2.64 Million - $3.31 Million	-45,629 Reduced 15.9%	241,373 $14.4 Million
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $2.34 Million - $2.65 Million	-35,997 Reduced 11.14%	287,002 $20.8 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $74,797 - $80,698	-1,105 Reduced 0.34%	322,999 $22.6 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $639,015 - $698,215	-10,068 Reduced 3.01%	324,104 $22.3 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $377,160 - $430,339	-6,286 Reduced 1.85%	334,172 $21.6 Million
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $1.46 Million - $1.66 Million	25,718 Added 8.17%	340,458 $19.8 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $2.57 Million - $3.23 Million	-41,389 Reduced 11.62%	314,740 $19.9 Million
Q2 2020 Aug 03, 2020	BUY	$72.34 - $84.0 $3.02 Million - $3.51 Million	41,744 Added 13.28%	356,129 $27.4 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $6.84 Million - $8.76 Million	-109,207 Reduced 25.78%	314,385 $23.5 Million
Q4 2019 Feb 18, 2020	BUY	$61.62 - $67.78 $2.71 Million - $2.98 Million	43,945 Added 11.58%	423,592 $27.5 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $1.45 Million - $1.6 Million	-23,146 Reduced 5.75%	379,647 $24.1 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $1.94 Million - $2.18 Million	-31,371 Reduced 7.23%	402,793 $27.2 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $52,900 - $59,262	846 Added 0.2%	434,164 $28.2 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $6.65 Million - $8.68 Million	-109,915 Reduced 20.23%	433,318 $27.1 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $3.23 Million - $3.57 Million	45,259 Added 9.09%	543,233 $41.9 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $1.91 Million - $2.23 Million	-29,502 Reduced 5.59%	497,974 $35.3 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $2.84 Million - $3.47 Million	-39,037 Reduced 6.89%	527,476 $39.8 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $4.36 Million - $5.12 Million	-61,327 Reduced 9.77%	566,513 $40.6 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $3.03 Million - $3.6 Million	42,065 Added 7.18%	627,840 $50.9 Million
Q2 2017 Aug 11, 2017	BUY	N/A	585,775	585,775 $41.5 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Gilead Sciences, Inc. Transaction History